89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 11,416,948 | $176,277,677 | 3.47% |
Orchard Capital Management, LLC | 542,879 | $8,382,052 | 3.10% |
Artia Global Partners LP | 465,465 | $7,186,780 | 2.99% |
Octagon Capital Advisors LP | 1,219,157 | $18,823,784 | 2.89% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,694,404 | $41,601,598 | 2.25% |
University of Wisconsin Foundation | 126,516 | $1,953,407 | 2.24% |
Tri Locum Partners LP | 249,571 | $3,853,376 | 1.23% |
Endurant Capital Management LP | 82,153 | $1,268,442 | 1.14% |
Parkman Healthcare Partners LLC | 363,553 | $5,613,258 | 1.03% |
ACUTA CAPITAL PARTNERS, LLC | 1,000 | $1,523,000 | 1.02% |
SPHERA FUNDS MANAGEMENT LTD. | 319,301 | $4,930,007 | 0.90% |
1492 Capital Management LLC | 78,404 | $1,210,558 | 0.78% |
BRAIDWELL LP | 1,590,387 | $24,555,575 | 0.78% |
BVF INC/IL | 1,846,154 | $28,504,618 | 0.77% |
Newtyn Management, LLC | 200,500 | $3,095,720 | 0.76% |
Ikarian Capital, LLC | 3,504 | $5,410,176 | 0.65% |
Logos Global Management LP | 310,000 | $4,786,400 | 0.64% |
Redmile Group, LLC | 761,955 | $11,764,585 | 0.56% |
Soleus Capital Management, L.P. | 346,033 | $5,342,750 | 0.49% |
Paradigm Biocapital Advisors LP | 329,100 | $5,081,304 | 0.34% |
External links
This page lists 89BIO INC's shareholders in Q3 2023. To view 89BIO INC's shareholder history, click here.